- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
Type 2 Diabetes Mellitus in China: A Preventable Economic BurdenTreatment of type 2 diabetes mellitus and its complications places a heavy burden on healthcare budgets in China and will continue to do so.
Latest:
Attributes Common to Programs That Successfully Treat High-Need, High-Cost IndividualsMany programs attempting to effectively treat high-need, high-cost individuals have not been able to lower spending, improve outcomes, or increase satisfaction. This paper suggests 8 attributes that many successful programs share.
Latest:
Population Targeting and Durability of Multimorbidity Collaborative Care ManagementBenefits of a patient-centered multimorbidity care management program occurred early, and were evident only among patients with depression and unfavorable medical control of diabetes and heart disease.
Latest:
Trends in Viral Hepatitis Cost-Effectiveness StudiesRegardless of the cause of bias, more awareness and scrutiny are needed when utilizing cost-effectiveness studies for healthcare decision making.
Latest:
A Value Proposition for Pragmatic Clinical TrialsThe authors examine the origin, benefits, and challenges of pragmatic clinical trials to assess the ultimate value of this research design.
Latest:
Biosimilars at ASH 2019: Data on Truxima and Competitors for EculizumabResults for Truxima, recently launched in the United States, and complement inhibitors were presented at the 61st American Society of Hematology Annual Meeting and Exposition.
Latest:
The FLU-FIT Program: An Effective Colorectal Cancer Screening Program for High Volume Flu Shot ClinicsOffering home fecal immunochemical tests to eligible patients during influenza vaccination clinic increases colorectal cancer screening rates.
Latest:
Cost-effectiveness Evaluation of a Home Blood Pressure Monitoring ProgramA technology-based, pharmacist-run home blood pressure monitoring program improves health outcomes by investing $20.50 per mm Hg systolic blood pressure lowered and $3300 per life-year gained.
Latest:
FDA Oncology Center of Excellence Moves Forward on Coordinated Clinical Reviews, Integrated Approach to the Clinical Evaluation of Oncology ProductsAn overview of the FDA's Oncology Center of Excellence-a collaborative approach to the clinical approval process.
Latest:
A Mid-South Chronic Disease Registry and Practice-Based Research Network to Address DisparitiesThe authors report the experience of one of the first Southern US communities to develop a comprehensive health care data repository for tracking processes and outcomes of care and identifying areas of greatest need.
Latest:
Screening Cardiac Surgery Patients for MRSA: An Economic Computer ModelRoutine preoperative MRSA screening of cardiac surgery patients could provide substantial economic value to third-party payers and hospitals under a wide range of circumstances.
Latest:
Variation in the Cost of Medications for the Treatment of Colorectal CancerUsing data from a nationwide registry, this study revealed significant variation in the use and cost of contemporary regimens for colorectal cancer.
Latest:
Improving Medication Understanding Among Latinos Through Illustrated Medication ListsA randomized controlled trial found that plain-language, illustrated medication lists improved medication understanding among Latinos.
Latest:
Health Insurance Literacy: Disparities by Race, Ethnicity, and Language PreferenceRacial/ethnic minorities are disproportionately at risk for adverse health and financial consequences due to lower health insurance literacy compared with white enrollees.
Latest:
Benefits and Risks of Live Attenuated Influenza Vaccine in Young ChildrenUse of live attenuated influenza vaccine in young children has a favorable benefit-risk profile.
Latest:
Geographic Variation in Surgical Outcomes and Cost Between the United States and JapanCompared with Japan, the United States has substantially less geographic variation in surgical outcomes, but it has higher variation in cost.
